The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD
Open accessAbstract
The association between proton pump inhibitors (PPI) use and risk of acute interstitial nephritis has been described. However, whether exposure to PPI associates with incident CKD, CKD progression, or ESRD is not known. We used Department of Veterans Affairs national databases to build a primary cohort of new users of PPI ( n =173,321) and new users of histamine H 2 -receptor antagonists (H 2 blockers; n =20,270) and followed these patients over 5 years to ascertain renal outcomes. In adjusted Cox survival models, the PPI group, compared with the H 2 blockers group, had an increased risk of incident eGFR<60 ml/min per 1.73 m 2 and of incident CKD (hazard ratio [HR], 1.22; 95% confidence interval [95% CI], 1.18 to 1.26; and HR, 1.28; 95% CI, 1.23 to 1.34, respectively). Patients treated with PPI also had a significantly elevated risk of doubling of serum creatinine level (HR, 1.53; 95% CI, 1.42 to 1.65), of eGFR decline >30% (HR, 1.32; 95% CI, 1.28 to 1.37), and of ESRD (HR, 1.96; 95% CI, 1.21 to 3.18). Furthermore, we detected a graded association between duration of PPI exposure and risk of renal outcomes among those exposed to PPI for 31–90, 91–180, 181–360, and 361–720 days compared with those exposed for ≤30 days. Examination of risk of renal outcomes in 1:1 propensity score-matched cohorts of patients taking H 2 blockers versus patients taking PPI and patients taking PPI versus controls yielded consistent results. Our results suggest that PPI exposure associates with increased risk of incident CKD, CKD progression, and ESRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Austin, P. C. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.568786 · Cited by 12,242
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis
Coca, S. G., Singanamala, S., & Parikh, C. R. (2012) · Kidney International · doi:10.1038/ki.2011.379 · Cited by 2,256
Acute Kidney Injury Increases Risk of ESRD among Elderly
Ishani, A., Xue, J. L., Himmelfarb, J., Eggers, P. W., Kimmel, P. L., Molitoris, B. A., & Collins, A. J. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007080837 · Cited by 1,194
Austin, P. C., Grootendorst, P., & Anderson, G. M. (2007) · Statistics in Medicine · doi:10.1002/sim.2580 · Cited by 1,137
Coresh, J., Turin, T. C., Matsushita, K., Sang, Y., Ballew, S. H., Appel, L. J., Arima, H., Chadban, S. J., Cirillo, M., Djurdjev, O., et al. (2014) · JAMA · doi:10.1001/jama.2014.6634 · Cited by 988
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Lazarus, B., Chen, Y., Wilson, F. P., Sang, Y., Chang, A. R., Coresh, J., & Grams, M. E. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7193 · Cited by 729
Stürmer, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiss, S. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 670
Propensity Score Methods for Confounding Control in Nonexperimental Research
Brookhart, M. A., Wyss, R., Layton, J. B., & Stürmer, T. (2013) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000359 · Cited by 588
Overprescribing proton pump inhibitors
Forgacs, I., & Loganayagam, A. (2008) · BMJ · doi:10.1136/bmj.39406.449456.be · Cited by 553
Praga, M., & González, E. (2010) · Kidney International · doi:10.1038/ki.2010.89 · Cited by 507
Drug-induced acute interstitial nephritis
Rossert, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060002804.x · Cited by 488
Drug-induced acute interstitial nephritis
Perazella, M. A., & Markowitz, G. S. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.71 · Cited by 378
Developing the Sentinel System — A National Resource for Evidence Development
Behrman, R. E., Benner, J. S., Brown, J. S., McClellan, M., Woodcock, J., & Platt, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1014427 · Cited by 323
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis
Hackam, D. G., Mamdani, M., Li, P., & Redelmeier, D. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68041-0 · Cited by 321
Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research
Yola, M., & Lucien, A. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90170-8 · Cited by 253
The incident user design in comparative effectiveness research
Johnson, E. S., Bartman, B. A., Briesacher, B. A., Fleming, N. S., Gerhard, T., Kornegay, C. J., Nourjah, P., Sauer, B., Schumock, G. T., Sedrakyan, A., et al. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3334 · Cited by 241
Blank, M.-L., Parkin, L., Paul, C., & Herbison, P. (2014) · Kidney International · doi:10.1038/ki.2014.74 · Cited by 213
Adverse Effects Associated With Proton Pump Inhibitors
Schoenfeld, A. J., & Grady, D. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7927 · Cited by 213
Antoniou, T., Macdonald, E. M., Hollands, S., Gomes, T., Mamdani, M. M., Garg, A. X., Paterson, J. M., & Juurlink, D. N. (2015) · CMAJ Open · doi:10.9778/cmajo.20140074 · Cited by 199
Proton-pump inhibitor use is associated with low serum magnesium concentrations
Danziger, J., William, J. H., Scott, D. J., Lee, J., Lehman, L.-W., Mark, R. G., Howell, M. D., Celi, L. A., & Mukamal, K. J. (2013) · Kidney International · doi:10.1038/ki.2012.452 · Cited by 183
Relation of Serum Lipids and Lipoproteins with Progression of CKD: The CRIC Study
Rahman, M., Yang, W., Akkina, S., Alper, A., Anderson, A. H., Appel, L. J., He, J., Raj, D. S., Schelling, J., Strauss, L., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09320913 · Cited by 176
Proton Pump Inhibitors and Hypomagnesemia in the General Population: A Population-Based Cohort Study
Kieboom, B. C. T., Jong, J. C. K., Eijgelsheim, M., Franco, O. H., Kuipers, E. J., Hofman, A., Zietse, R., Stricker, B. H. C., & Hoorn, E. J. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.05.012 · Cited by 161
Hypomagnesemia in Type 2 Diabetic Nephropathy
Sakaguchi, Y., Shoji, T., Hayashi, T., Suzuki, A., Shimizu, M., Mitsumoto, K., Kawabata, H., Niihata, K., Okada, N., Isaka, Y., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0226 · Cited by 156
Bowe, B. C., Xie, Y., Xian, H., Balasubramanian, S., & Al‐Aly, Z. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.034 · Cited by 156
Self-citationSiew, E. D., Parr, S. K., Abdel-Kader, K. F. M., Eden, S., Peterson, J. F., Bansal, N., Hung, A. M., Fly, J., Speroff, T., Ikizler, T. A., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121218 · Cited by 154
Long‐term use of acid suppression started inappropriately during hospitalization
Zink, D. A., Pohlman, M. C., Barnes, M. A., & Cannon, M. E. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02454.x · Cited by 140
Proton pump inhibitors and the kidney: critical review
Brewster, U. C., & Perazella, M. A. (2007) · Clinical Nephrology · doi:10.5414/cnp68065 · Cited by 137
Pham, P., Pham, P. M., Pham, P. A., Pham, S. V., Pham, H. V., Miller, J. M., Yanagawa, N., & Pham, P. T. T. (2005) · Clinical Nephrology · doi:10.5414/cnp63429 · Cited by 136
Tin, A., Grams, M. E., Maruthur, N. M., Astor, B. C., Couper, D. J., Mosley, T. H., Selvin, E., Coresh, J., & Kao, W. H. L. (2014) · Kidney International · doi:10.1038/ki.2014.331 · Cited by 133
Proton pump inhibitors and acute kidney injury: a nested case–control study
Klepser, D. G., Collier, D. S., & Cochran, G. L. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-150 · Cited by 128
Robb, M. A., Racoosin, J. A., Sherman, R. E., Gross, T. P., Ball, R., Reichman, M. E., Midthun, K., & Woodcock, J. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2311 · Cited by 118
The Nexus of Acute Kidney Injury, Chronic Kidney Disease, and World Kidney Day 2009
Okusa, M. D., Chertow, G. M., & Portilla, D. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06711208 · Cited by 115
Propensity scores: help or hype?
Winkelmayer, W. C., & Kurth, T. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh104 · Cited by 110
Proton pump inhibitor‐induced acute interstitial nephritis
Härmark, L., van der Wiel, H. E., de Groot, M., & van Grootheest, A. C. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02927.x · Cited by 108
Choudhry, M., Soran, H., & Ziglam, H. M. (2008) · QJM · doi:10.1093/qjmed/hcn035 · Cited by 99
Rate of Kidney Function Decline and Risk of Hospitalizations in Stage 3A CKD
Xie, Y., Bowe, B. C., Xian, H., Balasubramanian, S., & Al‐Aly, Z. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04480415 · Cited by 92
Self-citationMini-Sentinel and Regulatory Science — Big Data Rendered Fit and Functional
Psaty, B. M., & Breckenridge, A. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1401664 · Cited by 90
Textbook of Pharmacoepidemiology
Strom, B. L., & Kimmel, S. E. (2006) · Wiley eBooks · doi:10.1002/9781118707999 · Cited by 86
Veterans Health Administration inpatient and outpatient care data: an overview.
Murphy, P. A., Cowper, D. C., Seppala, G., Stroupe, K. T., & Hynes, D. M. (2002) · PubMed · Cited by 68
Proton-pump inhibitor use and hip fractures in men: a population-based case-control study
Adams, A. L., Black, M. H., Zhang, J. L., Shi, J. M., & Jacobsen, S. J. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.01.004 · Cited by 62
Xie, Y., Bowe, B. C., Xian, H., Balasubramanian, S., & Al‐Aly, Z. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.02.039 · Cited by 59
Self-citationIn support of descriptive studies; relevance to translational research
Marincola, F. M. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-21 · Cited by 53
Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death
Xie, Y., Bowe, B. C., Xian, H., Balasubramanian, S., & Al‐Aly, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149283 · Cited by 36
Self-citationReview of select causes of drug-induced AKI
Perazella, M. A., & Luciano, R. L. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.1045489 · Cited by 32
Pham, P., Pham, P. M., Pham, P. T., Pham, S. V., Pham, P. A., & Pham, P. T. (2009) · Clinical Nephrology · doi:10.5414/cnp71375 · Cited by 31
Veterans Affairs Research and Development: Using Science to Improve Health Care for Veterans
Oddone, E. Ž., & Eisen, S. A. (2008) · North Carolina Medical Journal · doi:10.18043/ncm.69.1.35 · Cited by 13
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
High-dimensional characterization of post-acute sequelae of COVID-19
Al-Aly, Z., Xie, Y., & Bowe, B. (2021) · Nature · doi:10.1038/s41586-021-03553-9 · Cited by 1,518
Xie, Y., Bowe, B., Mokdad, A. H., Xian, H., Yan, Y., Li, T., Maddukuri, G., Tsai, C.-Y., Floyd, T., & Al-Aly, Z. (2018) · Kidney International · doi:10.1016/j.kint.2018.04.011 · Cited by 1,391
Self-citationFreedberg, D. E., Kim, L. S., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 891
Moayyedi, P., Eikelboom, J. W., Bosch, J., Connolly, S. J., Dyal, L., Shestakovska, O., Leong, D., Anand, S. S., Störk, S., Branch, K. R. H., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.056 · Cited by 483
Metadata
- Authors
- Xie, Y., Bowe, B., Li, T., Xian, H., Balasubramanian, S., & Al-Aly, Z.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2016-03-14
- Volume
- 27
- Issue
- 10
- Pages
- 3153-3163
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- OpenAlex
- W2335909636
- Cited by
- 337
- References
- 49
- FWCI
- 39.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.